Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Ophthalmol ; 125(5): 703-4, 1998 May.
Article in English | MEDLINE | ID: mdl-9625557

ABSTRACT

PURPOSE: To evaluate the role of vitrectomy in patients with decreased visual acuity solely attributable to asteroid hyalosis. METHOD: We retrospectively reviewed the records of patients with asteroid hyalosis and identified those who underwent vitrectomy for symptomatic asteroid hyalosis alone. RESULTS: After vitrectomy, nine of 10 eyes (10 patients) had at least 1 line of improvement in nonstandardized best-corrected visual acuity. In one eye, vision was unchanged postoperatively. The average gain was 3.44 lines. CONCLUSIONS: A small percentage of patients with asteroid hyalosis have decreased visual acuity caused solely or primarily by the asteroid hyalosis. Vitrectomy in these patients may alleviate symptoms and improve visual acuity.


Subject(s)
Calcinosis/surgery , Vision Disorders/surgery , Visual Acuity , Vitrectomy , Vitreous Body/surgery , Aged , Aged, 80 and over , Calcinosis/complications , Eye Diseases/complications , Eye Diseases/surgery , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Vision Disorders/etiology
2.
Haemophilia ; 2(1): 63-4, 1996 Jan.
Article in English | MEDLINE | ID: mdl-27213911
3.
Ophthalmic Surg ; 25(6): 386-7, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8090419

ABSTRACT

Inadvertent cyclodialysis cleft formation is a rare complication of intraocular surgery. We report a patient in whom a hypotonus cyclodialysis cleft developed following the removal of an anterior chamber intraocular lens. The cleft closed and the hypotony resolved after 1 month of topical atropine therapy.


Subject(s)
Anterior Chamber/surgery , Ciliary Body , Lenses, Intraocular/adverse effects , Ocular Hypotension/etiology , Uveal Diseases/etiology , Aged , Atropine/therapeutic use , Cataract Extraction , Humans , Intraocular Pressure , Male , Ocular Hypotension/therapy , Uveal Diseases/therapy , Visual Acuity
4.
J Fla Med Assoc ; 81(4): 236-9, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8046360

ABSTRACT

Diabetic retinopathy is a major cause of morbidity and the leading cause of legal blindness in working-age persons in the United States. Retinopathy affects both juvenile-onset and noninsulin dependent diabetics. Most visual loss occurs in patients because they are seen late in the course of their disease. Several clinical trials have aided in establishing recommended screening and referral guidelines for patients with diabetes mellitus. Treatment strategies based on clinical trials are reviewed as well as the importance of control of both hyperglycemia and hypertension. Ocular findings are illustrated and discussed. The primary care physician can substantially reduce the risk of blindness and visual impairment in diabetic patients by prompt recognition of the ocular findings and understanding the importance of timely ophthalmologic evaluation.


Subject(s)
Diabetic Retinopathy/diagnosis , Blindness/etiology , Diabetic Retinopathy/complications , Diabetic Retinopathy/therapy , Family Practice , Humans , Referral and Consultation , Visual Acuity
5.
Ann Ophthalmol ; 25(3): 100-2, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8460881

ABSTRACT

Renal cell carcinoma (RCC) is a tumor of middle-aged men that metastasizes to the lung, liver, and bone. Few cases of RCC metastatic to the orbit have been reported. When this tumor spreads to the orbit, the orbital metastasis is likely to be the first indication of the cancer. We report the case of a 53-year-old man with widespread metastatic RCC whose first sign of disease was a metastatic orbital tumor. External and ocular examination and computed tomographic and histopathologic findings are described. The clinical characteristics, treatment, and prognosis of metastatic RCC are discussed.


Subject(s)
Carcinoma, Renal Cell/secondary , Kidney Neoplasms/pathology , Orbital Neoplasms/secondary , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/radiotherapy , Exophthalmos/pathology , Humans , Kidney Neoplasms/diagnostic imaging , Kidney Neoplasms/radiotherapy , Male , Middle Aged , Orbital Neoplasms/diagnostic imaging , Orbital Neoplasms/radiotherapy , Prognosis , Tomography, X-Ray Computed , Visual Acuity
7.
Arch Ophthalmol ; 110(3): 378-80, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1543457

ABSTRACT

A 35-year-old man with a history of repeated previous facial injuries presented with acute onset of a right orbital mass less than 2 weeks after blunt trauma to the right eye. Orbital B-scan ultrasonography and computed tomography showed an intraconal cystic lesion. The tumor was excised via lateral orbitotomy. Pathologic evaluation demonstrated a hematic cyst containing fresh blood. The presence of hemosiderin in the cyst wall suggested recent bleeding in a preexisting orbital hemorrhagic lesion. Patients with hematic cysts of the orbit usually present with a subperiosteal mass months to years after trauma.


Subject(s)
Cysts/etiology , Eye Injuries/complications , Orbit/injuries , Orbital Diseases/etiology , Adult , Cysts/diagnosis , Facial Injuries/complications , Fundus Oculi , Hematoma/etiology , Humans , Male , Orbital Diseases/diagnosis , Tomography, X-Ray Computed , Visual Acuity
8.
Arch Dermatol ; 120(12): 1585-90, 1984 Dec.
Article in English | MEDLINE | ID: mdl-6508330

ABSTRACT

Seventy-six patients with mycosis fungoides (MF) were given topical mechlorethamine hydrochloride therapy. Allergic contact hypersensitivity reactions to the drug developed in 51 patients (67.1%). Sixty-four patients of the original 76 continued therapy, with 43 (67.2%) achieving a complete remission and 12 (18.8%) achieving a partial remission. Stage I disease responded significantly better than did subsequent, more severe disease stages. The median times to complete remission were 5.6 months, 32.3 months, and 22.3 months for stage I, II, and III disease, respectively. The conditions of patients with contact sensitivity did not respond better than those of patients without contact sensitivity. Patients with substage A disease did not respond better patients with substage B disease. These findings are encouraging and indicate that the use of topically applied mechlorethamine for early-stage MF should be continued, despite the development of contact dermatitis to the drug.


Subject(s)
Mechlorethamine/therapeutic use , Mycosis Fungoides/drug therapy , Skin Neoplasms/drug therapy , Administration, Topical , Adolescent , Adult , Aged , Child , Drug Hypersensitivity/etiology , Female , Humans , Hypersensitivity, Delayed/chemically induced , Male , Mechlorethamine/administration & dosage , Mechlorethamine/adverse effects , Middle Aged , Mycosis Fungoides/pathology , Skin Neoplasms/pathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...